A 300 ml can of Avene Thermal Spring Water carried a maximum retail price of ₹2,376 at Apollo Pharmacy and ₹2,800 on Amazon India, both read on 4 September 2026. French pharmacies were selling the same can that day for €7.50 to €9.90. The can holds spring water and nitrogen gas. This audit is about who owns the brand, who brings it here, and what the number printed on the box lets you check.
Avene belongs to Laboratoires Pierre Fabre, whose majority shareholder is a charitable foundation holding 86.3% of the capital. It reaches India through A. Menarini India, a third-party distributor, and on the two products measured on 4 September 2026 it sold here at roughly 1.5 to 1.75 times the French reference price. Its Indian pack prints a CDSCO import registration number, RC/COS-003873 — and that number is the most useful thing on the label.
Snapshot
- Brand
- Eau Thermale Avene, named after Avene-les-Bains in the Herault, southern France
- First products
- 1975, made at the spring; Laboratoires Pierre Fabre founded 1962 in Castres
- Owner
- Laboratoires Pierre Fabre. The Pierre Fabre Foundation holds 86.3%; employees hold nearly 10%
- Scale
- Group revenue €3.2 billion in 2025. Avene alone passed €1 billion in 2023
- Made in
- Avene, France — the pack names Pierre Fabre Dermo-Cosmetique, Unite de production Avene, 34260
- Imported and marketed in India by
- A. Menarini India Pvt Ltd, since 27 December 2023
- Registration number on the pack
- RC No. RC/COS-003873
- Indian price band
- ₹858 to ₹3,500 at MRP; ₹772 to ₹3,150 selling, checked 4 September 2026
How it started
The founding story is a horse. The brand’s own history page says the spring’s properties were discovered in 1736, when a horse belonging to the Marquis of Rocozels, suffering from a skin disease, rolled in the water regularly. In 1743 the Montpellier Academy of Medicine recognised it. These are brand legends told by the brand — La Roche-Posay, the other French thermal water house, has a founding horse too.
The company underneath is younger and better documented. Pierre Fabre, a pharmacist, founded his laboratory in Castres in 1962 with eight employees. His group bought the Avene hydrotherapy centre in 1966 and began making products at the spring in 1975, siting the factory there so the water would not have to be moved.
- 1736The spring’s properties recorded, per the brand’s own history
- 1962Pierre Fabre founds his laboratory in Castres with eight employees
- 1966The group buys the Avene hydrotherapy centre
- 1975First Eau Thermale Avene products, made at the spring
- 1999The Pierre Fabre Foundation is recognised as being of public utility
- 2013The foundation holds 86% of the group’s capital
- 2023Avene becomes the group’s first brand to pass €1 billion in turnover
Three different clocks are used to sell the brand: “over 275 years”, “since 1990”, and a first product in 1975.
Pierre Fabre and Fondation Pierre Fabre corporate pages and the brand’s own history page, read 4 September 2026.
The ownership is the part most coverage gets wrong. Avene is routinely called a family-owned French company. Pierre Fabre says its majority shareholder is the Pierre Fabre Foundation, holding 86.3% of the capital, described as a humanitarian foundation recognised as being of public utility. Its own employees are the second-largest shareholder at nearly 10%, through a scheme running since 2005. Fabre made the foundation his sole legatee, which is how it came to control the group.
So the company that makes Avene answers to a charitable foundation and its own staff rather than to a stock market or a family. That is unusual, and it is the second French dermatological group on this shelf built that way — Bioderma’s owner NAOS is governed by a shareholder foundation too. It is a fact about who takes the decisions. It is not a guarantee about how they are taken, and it changes nothing about how a claim on a bottle should be judged. Every figure above is the company’s and the foundation’s own account of themselves.
Group revenue was €3.2 billion in 2025, 71% of it international, across 130 territories. Avene alone passed €1 billion of turnover in 2023 on 130 million units. Brand-level revenue is rare — CeraVe, La Roche-Posay, Vichy and Eucerin publish none — and Avene deserves the credit for printing it.
What they actually make
Apollo Pharmacy lists 53 Avene products in India, a narrower range than the French one and weighted to two heroes and sun care: the Thermal Spring Water spray in 50 ml, 150 ml and 300 ml; Cicalfate+ Restorative Protective Cream in 40 ml and 100 ml; the Cleanance line for acne-prone skin; and at least seven SPF 50 or 50+ products. XeraCalm, Antirougeurs and DermAbsolu do not make the trip.
The Cicalfate+ claims are the best-footnoted set on this shelf and deserve saying so. The 48-hour repair claim carries a protocol: a clinical study under dermatological, paediatric and gynaecological control, 248 subjects, two applications a day for 21 days, with clinical scoring at 48 hours. A panel of 248 is an order of magnitude above the consumer panels this category usually runs on.
Then the four claims separate into four different kinds of evidence, and the footnotes say so. The 48-hour result is clinically scored. “90% fewer visible marks” is footnoted as a satisfaction percentage — the footnote’s own words are “% de satisfaction”, 244 patients over 21 days, which is what people reported. “2.5 times faster barrier repair” is footnoted as an in-vitro test on keratinocyte migration in a dish at 24 hours, treated against untreated; that is a result in glassware, not on skin, and Avene labels it itself. “Proven on more than 4,000 patients” is footnoted as a cumulative head-count across development, marketing and post-launch studies, multi-indication — not one trial of 4,000 people. None of these footnotes appears on the Indian site, which publishes brand pillars and no numbered claims.
The thermal water claims are a step behind. The 30% reduction in skin sensitivity is footnoted to seven days of twice-daily use, with no panel size given on the page. A French pharmacy’s page for the same can, dated 1 September 2026, attaches the same 30% to five minutes. Where a retailer’s copy and the brand’s own footnote give different conditions, go by the footnote. The history page’s line, “More Than 150 Studies Prove Its Efficacy”, names, dates and links none of them.
On dermatologist recommendation, Avene does better than most. Pierre Fabre’s brand page carries a real footnote — “Study based on internal data collected from more than 90 countries and an IQVIA survey in 8 countries in 2021”. It names a research house, a year and a scope. It also sits on a corporate page rather than on the Indian site or the pack, it mixes internal data with a survey, and it does not say which eight countries. The separate figure of 80,000 prescribers carries no footnote at all.
The sun care is where the shelf falls silent. Avene sells at least seven SPF 50 or 50+ products in India, from a ₹1,999 Invisible Ultra Fluid to a ₹3,500 200 ml spray. No SPF test report, test method, testing standard, laboratory or PA rating is published for any of them on the brand’s Indian, French or American pages. The number is on the bottle and nothing behind the number is published — which is true of every French and German derm brand on this shelf.
What Avene costs in India
Avene has no Indian company of its own. It is imported and marketed here by A. Menarini India Pvt Ltd, the Indian arm of an Italian pharmaceutical group, under an exclusive partnership announced on 27 December 2023. Before that, Pierre Fabre sold the brand here through Abbott Healthcare, a partnership renewed in February 2015. Anyone who bought Avene in India before 2024 bought it from a different company than a buyer does today.
- Pierre Fabre Dermo-Cosmetique, 34260 Avene, FranceNamed on the pack as the manufacturer, at the spring itself
- A. Menarini India Pvt LtdImports and markets the brand in India since 27 December 2023; Abbott Healthcare before that
- Apollo, Nykaa, Clinikally, Amazon IndiaMRP ₹858 to ₹3,500, read 4 September 2026
That middle step is the difference between this brand and its neighbours. Bioderma is imported by NAOS’s own Indian subsidiary, Eucerin by Beiersdorf’s own Nivea India, La Roche-Posay by L’Oreal India. All three sell here for roughly half to two-thirds of their European reference prices. Avene and Vichy, which do not arrive that way, sell here at a premium. That is five products measured on one day, and it is a reading rather than a proved mechanism — an extra commercial party in the chain has to be paid, but a third-party distributor also carries the cost of building a market, and Avene’s Indian range is far deeper than Vichy’s.
- France, reference price (300 ml spray)
- €14.50 = ₹1,604
- India, MRP at Apollo Pharmacy
- ₹2,376
- Gap
- +48%
- Checked on
- 4 September 2026
Against the Amazon India MRP of ₹2,800 the gap is +75%. Against what a French shopper actually pays — €7.50 to €9.90, because French pharmacies discount this product by a third to a half — the Indian selling price is roughly double. Cicalfate+ runs the same way: about 1.5 times France on the 40 ml tube and about 1.8 times on the 100 ml. Two products, two retail sets, one direction. Rates used are the Federal Reserve H.10 release of 31 August 2026, at ₹110.62 to the euro.
Inside India, the size ladder matters more than the brand comparison.
| Product and size | MRP | ₹ per ml at MRP |
|---|---|---|
| Thermal Spring Water, 50 ml | ₹858 | ₹17.16 |
| Thermal Spring Water, 150 ml | ₹1,650 | ₹11.00 |
| Thermal Spring Water, 300 ml | ₹2,376 | ₹7.92 |
| Cicalfate+ Cream, 40 ml | ₹1,599 | ₹39.98 |
| Cicalfate+ Cream, 100 ml | ₹2,599 | ₹25.99 |
| Cleanance Cleansing Gel, 200 ml | ₹1,650 | ₹8.25 |
| Cleanance Sunscreen SPF 50+, 50 ml | ₹2,499 | ₹49.98 |
Apollo Pharmacy, 4 September 2026. The small can costs more than twice as much per millilitre as the big one, and the 40 ml Cicalfate+ tube is 54% dearer per millilitre than the 100 ml. That size penalty is the standard trap in Indian skincare pricing, and it shows up on the MRP-versus-selling-price gap that runs through footwear too — Metro discounts off a printed MRP in much the same way.
Who Avene is actually for
French retailer listings give the 300 ml aerosol two ingredients: thermal water and nitrogen. In India it costs ₹7.92 a millilitre at its best size and ₹17.16 at its worst.
For comparison, Bioderma’s Sensibio H2O, a formulated micellar cleanser sold on the same pharmacy shelf, works out at ₹2.30 a millilitre. That is not a verdict on whether Avene’s water does anything. It is the number that decides whether the price is worth paying to you, and you should have it before the shop assistant does.
Avene is for someone whose skin reacts to most things and who has found that this water helps — a common experience no audit can argue with. It is also for anyone who wants a repair cream whose maker publishes the protocol behind the claim, which Cicalfate+ does and most of its rivals do not. It is a poor buy for anyone who wants a sunscreen with published test data, and a poor buy in the 50 ml can at any time.
The brand-versus-importer split is worth understanding before you complain to anyone. Pierre Fabre makes the product; A. Menarini India is who answers the phone here. The customer-care contact on the Indian Facebook page runs to Menarini’s Asia-Pacific arm, not to France. That separation is ordinary in India — Bata India is a listed Indian company distinct from the brand’s founding house, while Campus both owns the brand and runs the factories. Knowing which shape you are dealing with tells you who is responsible for the price and the stock.
Reputation and controversies
Start with advertising, and with what was actually asked of the record. The Advertising Standards Council of India publishes its complaint outcomes. Searched on 4 September 2026 under two terms, “Avene” and “Pierre Fabre”, the outcomes file holds nothing for either. That is two terms on one day. Since December 2023 the advertiser of record for Avene in India has been A. Menarini India, and the file was not searched under that name. So this page does not hand Avene a clean advertising record — it gives you the terms, the date, and the term that has not been tried.
Two limits apply to that council in any case. It is a self-regulatory industry body rather than a statutory regulator, and its rulings go to a specific advertisement as it stood on a specific date. Nothing in its file amounts to a ruling on the pages or packs as they read today, in either direction.
Searches of Indian Kanoon on 4 September 2026 under the brand name, the French owner’s name and the Indian distributor’s name found no Indian court decision concerning Avene. The distributor’s own corporate matters are a separate company’s affairs, none of them read to an outcome, so none appears here. Indian Kanoon does not index every forum, and consumer commissions are patchily covered. Read that as nothing found rather than nothing there.
What the record does hold is about pricing and about labels. On 4 September 2026 the same 300 ml can carried two different maximum retail prices: ₹2,376 on Apollo Pharmacy and ₹2,800 on Amazon India, an 18% spread between two statements of a ceiling that is meant to be one number. On the same day a cross-border seller listed the 40 ml Cicalfate+ tube at an “MRP” of ₹6,052, selling at ₹4,656, while Indian pharmacies ran ₹1,318 to ₹1,599. A cross-border listing’s “MRP” is the seller’s own figure, not an Indian one.
On animal testing, PETA’s Beauty Without Bunnies directory carries a brand entry reading “Avene may not be cruelty-free”, explained as “This company hasn’t signed PETA’s statement of assurance to join the gold standard for cruelty-free certifications and be listed in our database”. Read those words exactly: that is PETA’s category for a company that has not signed, not a finding that it tests on animals, and it is a weaker listing than the one L’Oreal carries. Testing cosmetics on animals has been illegal in India since 2014. No cruelty-free claim, badge or certifier mark appears on the brand’s Indian, French or American sites, and no animal-testing policy statement from Pierre Fabre was located.
Buying it in India
Here is where Avene does something almost nothing else on this shelf does. Its Indian pack prints its import registration number. Under the Cosmetics Rules 2020, made under the Drugs and Cosmetics Act 1940, an imported cosmetic must be registered with the CDSCO before it comes in — application on Form COS-1, certificate on Form COS-2 — and the imported pack must carry that registration certificate number together with the certificate holder’s name and address and the actual manufacturer’s name and premises. Avene’s reads RC No. RC/COS-003873.
The register itself is not open to the public, so nobody outside can look a number up and see what it covers. What the rule gives you instead is a thing to demand. An imported cosmetic sold legally in India should have an RC number on the box. If the box in your hand does not carry one, ask the seller for it. That is a check any buyer can run in a shop, and it is the reason this number is worth memorising as a shape rather than as a value.
The pack prints a registration number; the register behind it is not open to the public. Treat the number as something to look for and match on the box, not as something you can verify online.
Find the RC number
On an imported cosmetic, look for “RC No.” on the pack alongside the importer’s name and address. Avene’s is RC/COS-003873. No number on the box is a question for the seller.
Ignore the country-of-origin dropdown
Amazon India’s structured “Country of Origin” field says India for Avene. The free-text block on the same listing says the product is manufactured at 34260 Avene, France. Only the free text is the declaration. That field has read India for German-made stock too.
Read the manufacturer line, then the importer line
They are two different companies here: Pierre Fabre Dermo-Cosmetique makes it in France, A. Menarini India Pvt Ltd imports and markets it. Three checkable things on one label.
Divide before you pay
Take the MRP, divide by the millilitres, and compare sizes before brands. On this range the answer is almost always the biggest pack you will finish.
Treat a cross-border price as a different market
A listing quoting an “MRP” three times the pharmacy price is not selling into the Indian MRP system. Buy from a pharmacy or a retailer that shows the Indian declaration block.
Common questions
Who owns Avene?
Laboratoires Pierre Fabre, a French group founded in Castres in 1962. Pierre Fabre says its majority shareholder is the Pierre Fabre Foundation, holding 86.3% of the capital, with employees holding nearly 10%. It is not listed and it is not family-owned in the ordinary sense.
Is Avene made in India?
No. The free-text declaration on the Indian listing read on 4 September 2026 names Pierre Fabre Dermo-Cosmetique, Unite de production Avene, 34260 Avene, France as the manufacturer. Amazon’s structured country-of-origin field says India on the same listing; only the free-text block is the declaration.
Why does Avene cost more in India than in France?
On the two products measured on 4 September 2026 the Indian price ran about 1.5 to 1.75 times the French reference price. Avene reaches India through a third-party distributor rather than the owner’s own subsidiary, which is one reading of the gap. No duty or margin figure is asserted here because none was read from a primary source.
What is the RC number on an Avene box?
It is the CDSCO import registration certificate number. The Cosmetics Rules 2020 require an imported cosmetic to be registered and require the pack to carry that number with the certificate holder’s and manufacturer’s details. Avene’s reads RC/COS-003873. The register is not publicly searchable, so the number is something to look for on the box rather than to check online.
Is Avene cruelty-free?
PETA’s directory lists it as “may not be cruelty-free”, which is its category for a company that has not signed PETA’s statement of assurance. That is not a finding that the company tests on animals. Testing cosmetics on animals has been illegal in India since 2014, and no cruelty-free badge appears on the brand’s own sites.
How we research and verify brand audits: our methodology.
References
- Pierre Fabre, About Laboratoires Pierre Fabre, 4 September 2026 — the 86.3% foundation holding, the near-10% employee stake, €3.2 billion 2025 revenue, 10,000 employees, 130 territories
- Fondation Pierre Fabre, History, 4 September 2026 — the 1999 public-utility recognition and the foundation reaching 86% of capital in 2013
- Pierre Fabre, 60 Years of Innovation and Commitment, 4 September 2026 — the 1962 founding in Castres, eight employees, and the sole-legatee arrangement
- Pierre Fabre, Eau Thermale Avene reaches €1 billion, 4 September 2026 — the 2023 billion-euro figure, 130 million units, 115 markets, 80,000 prescribers, “since 1990”
- Pierre Fabre, Caring for the skin, 4 September 2026 — the IQVIA 2021 footnote behind the dermatologist claim
- Eau Thermale Avene, History, 4 September 2026 — 1736, 1743, 1966, 1975, 1990, 2004 and the “more than 150 studies” line
- Eau Thermale Avene, Cicalfate range, 4 September 2026 — the four footnoted claims with their protocols, panel sizes and the in-vitro label
- Eau Thermale Avene, Eau Thermale range, 4 September 2026 — the thermal water claims and the seven-day footnote on the 30% figure
- Amazon India, Avene Thermal Spring Water 300 ml, 4 September 2026 — the manufacturer and importer declaration, RC No. RC/COS-003873, and the ₹2,800 MRP
- Apollo Pharmacy, Avene brand page, 4 September 2026 — the 53-product Indian range and every Indian MRP and selling price in the table
- ANI News, Menarini partners with Pierre Fabre Laboratories in India, 27 December 2023 — the exclusive Indian distribution partnership
- PR Newswire India, Pierre Fabre Dermo-Cosmetic and Abbott Healthcare, 27 February 2015 — the earlier Indian distribution arrangement
- Redcare Pharmacie, Eau Thermale 300 ml, 4 September 2026 — the €14.50 reference price and the €9.69 selling price
- PETA, Beauty Without Bunnies, Avene, 4 September 2026 — the “may not be cruelty-free” listing and its stated reason
- CDSCO, Guidance Document on Registration and Import of Cosmetics into India, 19 January 2021 — the registration requirement, Forms COS-1 and COS-2, and what the imported pack must carry
- Federal Reserve H.10 foreign exchange rates, released 31 August 2026 — the ₹110.62 to the euro used in every conversion above
Avene is better at showing its work than most of the pharmacy shelf. Cicalfate+ carries a real protocol behind its 48-hour claim — 248 subjects, 21 days, under medical control — and the brand labels its own 2.5-times figure as an in-vitro test rather than burying it. The dermatologist claim has an IQVIA footnote where three rivals have nothing. And its Indian pack prints RC/COS-003873, which is more than any other imported brand on this shelf gives an Indian buyer to hold on to.
The price is the problem. On both products measured on 4 September 2026 India paid roughly 1.5 to 1.75 times the French reference price, and about double what a French shopper actually pays at the till — while Bioderma, Eucerin and La Roche-Posay, all imported by their owners’ own Indian companies, sell here for half to two-thirds of Europe. The sun care carries no published test data at all, which matters more in Delhi than in Lyon. And the same 300 ml can was sold under two different maximum retail prices on one day, 18% apart.
Buy the 300 ml can and the 100 ml tube or do not bother: at ₹17.16 a millilitre the 50 ml spray is a charge for convenience, and there is nothing in the bottle but water and gas.
